Neurotrophin receptor-interacting MAGE (NRAGE) is the most recently identified p75 neurotrophin receptor (p75 NTR ) intracellular binding protein. Previously, NRAGE over-expression was shown to mediate cell cycle arrest and facilitate nerve growth factor (NGF) dependent apoptosis of sympathetic neuroblasts in a p75 NTR specific manner. Here we have examined the temporal and spatial expression patterns of NRAGE over the course of murine embryogenesis to determine whether NRAGE's expression is consistent with its proposed functions. We demonstrate that NRAGE mRNA and protein are expressed throughout embryonic and adult tissues. The mRNA is constitutively expressed within each tissue across development. However, expression of NRAGE protein displays a tight temporal tissue specific regulation. During early CNS development, NRAGE protein is expressed throughout the neural tube, but by later stages of neurogenesis, NRAGE protein is restricted within the ventricular zone, subplate and cortical plate. Moreover, NRAGE protein expression is limited to proliferative neural subpopulations as we fail to detect NRAGE expression co-localized with mature/differentiation associated neuronal markers. Interestingly, NRAGE's expression is not restricted solely to areas of p75 NTR expression suggesting that NRAGE may mediate proliferation and/or apoptosis from other environmental signals in addition to NGF within the CNS. Our data support previously characterized roles for NRAGE as a mediator of precursor apoptosis and a repressor of cell cycle progression in neural development. q
Introduction
In the course of development, the generation of neurons and glia from neural stem cells is regulated at steps that include lineage commitment, progenitor proliferation, differentiation, cellular migration and programmed cell death (apoptosis). Apoptosis is crucial for regulating not only the normal number of terminally differentiated neurons and glia, but also the number of neural progenitors (Nijhawan et al., 2000; de la Rosa and de Pablo, 2000) .
In the classic neurotrophic theory, postmitotic neurons compete for limited amounts of trophic factors, the neurotrophins, which mediate neuronal survival. Neurotrophins include four distinct and structurally related homodimeric compounds. Members of this family include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT3) and neurotrophin-4/5 (NT4/5) (Lindsay et al., 1994; Friedman and Greene, 1999) . These molecules act on neurons by binding to distinct classes of membrane receptors (Bothwell, 1995) . One class consists of p75 neurotrophin receptor (p75 NTR ), a member of the tumour necrosis factor (TNF)/Fas/CD40 receptor superfamily that binds all the four neurotrophins with relatively low affinity (Bothwell, 1996; Barrett, 2000) . The other class consists of Trk receptor tyrosine kinases, including TrkA, B and C and their various isoforms. Binding of neurotrophins to Trks is specific, with NGF binding to TrkA, BDNF to TrkB and NT-3 binding to TrkC and to a lesser extent TrkA (Kaplan and Miller, 2000; Bibel and Barde, 2000) . Individual Trks are necessary and sufficient to confer a functional response to their cognate ligands in the absence of p75 NTR . However, Trk and p75 NTR are often co-expressed endogenously and in vitro data have shown that p75 NTR increases the affinity of NGF binding TrkA (Hempstead et al., 1991) and enhances TrkA autophosphorylation Barker and Shooter, 1994) .
Despite the observations that Trk and p75 NTR coordinate neurotrophin-dependent survival of neurons, evidence is mounting indicating that p75 NTR can act independently of Trk as an inducer of cellular apoptosis (Barrett, 2000) . Ligand mediated p75 NTR -dependent apoptosis has been demonstrated within several developing neuronal lineages including sensory neurons (Barrett and Bartlett, 1994; Davey and Davies, 1998) , sympathetic neurons (Bamji et al., 1998) , motoneurons (Wiese et al., 1999; Sedel et al., 1999) and within non-neuronal lineages such as oligodendrocytes (Casaccia-Bonnefil et al., 1996) , and Schwann cells (Soilu-Hanninen et al., 1999) . In vivo evidence also supports a role for p75 NTR in apoptosis. Endogenous NGF binding p75 NTR induces apoptosis in developing chick retina neurons (Frade et al., 1996) . Further evidence suggesting that p75 NTR independently regulates cellular apoptosis comes from transgenic over-expression and knockout studies. Mice overexpressing the intracellular domain of the p75 NTR resulted in a dramatic increase in neuronal death in both the central and peripheral nervous system (Majdan et al., 1997) and mice lacking genes for ngf and/or p75 NTR have reduced cell death in the retina and in the mantle zone of the spinal cord von Schack et al., 2001) .
In an attempt to identify down-stream modulators of p75 NTR signaling, several groups have successfully utilized the yeast two-hybrid paradigm. Two zinc finger proteins named Schwann cell factor-1 (SC-1) (Chittka and Chao, 1999) and neurotrophic receptor interacting factor (NRIF) (Casademunt et al., 1999) have been shown to interact with the juxtamembrane region of p75 NTR . A third protein, neurotrophin receptor associated cell death executor or NADE (Mukai et al., 2000) associates with the intracellular p75 NTR death domain. These p75 NTR interacting proteins functionally have been associated with either cell cycle regulation (SC-1) (Chittka and Chao, 1999) or NGF-dependent apoptosis (NADE and NRIF) (Casademunt et al., 1999; Mukai et al., 2000) . SC-1 over-expression in proliferating cells induces cell cycle arrest by a currently unknown mechanism, although it may be directly involved in the down regulation of c-myc expression. NRIF knockout mice showed reduced levels of apoptosis in the retina, and this reduction was quantitatively similar to that seen in p75 NTR null mice. NADE also is involved in p75 NTR -mediated apoptosis by regulating the activation of caspase-3 upon NGF/ p75 NTR interactions (Mukai et al., 2000) . We have cloned and characterized an additional p75 NTR interacting protein we termed NRAGE for Neurotrophin receptor-interacting MAGE homolog (Salehi et al., 2000) . NRAGE, previously reported as MAGED1, is a member of the MAGE gene family that have previously been shown to code for surface antigens expressed by tumour cells but recently have been implicated on regulating cell cycle progression, apoptosis and neurogenic disorders (Lucas et al., 1999; Salehi et al., 2000; Kubu et al., 2000; Saburi et al., 2001; Barker and Salehi, 2002) . NRAGE, like SC-1 and NRIF, associates with the juxtamembrane region of p75 NTR and over-expression mediates both cell cycle arrest in proliferating cells, as well as an NGF-p75 NTR -dependent apoptosis of sympathetic neuroblasts. Therefore, NRAGE may posses multiple functions in vivo as a growth arrest protein and as a pro-apoptotic protein.
Until recently, MAGE gene expression was believed to be restricted primarily to tumour cells with the exception of male germ cells and placental cells (Hara et al., 1999) . However, one notable exception is the MAGE family member necdin. Necdin is expressed in virtually all postmitotic neurons and is believed to function as a differentiation associated growth suppressor (Hayashi et al., 1995; Uetsuki et al., 1996) . Recently a subbranch of the MAGE family tree, consisting in part with MAGED1 (NRAGE), have been reported to be expressed in a variety of normal as well as transformed cells (Lucas et al., 1999; Salehi et al., 2000; Kubu et al., 2000; Saburi et al., 2001; Barker and Salehi, 2002) . Therefore, since NRAGE or MAGED1 may possess multiple functions during embryogenesis, a detailed account of the spatial and temporal regulation of NRAGE expression is warranted in order to decipher the functional significance of NRAGE expression during development.
Here, we report the developmental expression of NRAGE during murine embryogenesis. Both the mRNA and protein are ubiquitously expressed. NRAGE message is detectable early in embryonic development and is expressed in all tissues examined into adulthood. However, the expression of NRAGE protein is strongly temporally and spatially regulated in a tissue specific manner. During cortical neurogenesis, NRAGE protein expression becomes restricted to areas of active cellular proliferation and regions where trophic-dependent apoptosis predominantly occurs. In the peripheral nervous system NRAGE, protein levels fluctuate in concert with sympathetic neuroblasts exiting the cell cycle and undergoing trophic factor mediated cell death. However, this early phase of NRAGE expression is in the absence of any detectable NGF receptors strongly suggesting that NRAGE functions are independent of p75 NTR in mediated neuroblasts mitotic arrest or apoptosis. Taken together these results demonstrate that NRAGE protein expression yields a complex spatial and temporal regulation supporting a dual role as a growth arrest protein and a mediator of p75 NTR regulated apoptosis.
Materials and methods

Embryo and tissue collection
Time pregnant matings of CD1 mice were established at the Robarts Research Institute breeding facility. The observation of the vaginal plug was designated as embryonic day 0.5 (E0.5). Time pregnant Sprague-Dawley rats were purchased from the Charles River Company (Montreal, QE, Canada).
Pregnant mice were sacrificed on consecutive days (E7-E21). The embryos were dissected from the uterus in RNAse free phosphate-buffered saline (PBS) pH 7.4, washed in PBS and fixed in 4% paraformaldehyde (PFA) in PBS. Ten micrometer sections of paraffin embedded tissues were generated using a progressive instrumentation microtome (Fisher).
Murine tissues (E10-adult), listed in Table 1 , were harvested, frozen in liquid nitrogen and stored at 2808C until use. Embryonic brain was obtained by dissecting directly caudle to the mandible and subsequently removing the skull and meninges. Neural tubes (somites 1-4, 5-12, 13-caudle) with somites removed but with adjacent sympathetic and dorsal root ganglia were maintained.
B2 sympathetic neuroblasts isolations
Sympathetic ganglia's were dissected from embryonic Sprague-Dawley rats from E13-E18 of gestation. The sympathetic chains were isolated from thoracolumbar regions and treated with a combination of 1 mg/ml elastase and 1 mg/ml collagenase in minimal essential medium at 378C for 30 min. The cells were stained with the B2 antibody and positive cells were isolated using fluorescence activated cell sorting . B2 1 sympathetic precursors were plated in a serum-free modification of L15N2 medium as described in detail elsewhere Wolinsky et al., 1985) .
Northern blotting
Mouse and rat poly-A enriched multiple tissue Northern blots were purchased from Clontech. A blot containing total RNA from normal human tissues was purchased from Invitrogen. Both human and mouse blots were probed with a 300 base pair (bp) fragment of human NRAGE. This fragment was generated by polymerase chain reaction (PCR) over a common sequence (forward primer, 5 0 -TTT AGT AGT GGC ATT CTG GG-3 0 ; reverse primer, 5 0 -CCC AAC TGC CAA TGA GAT GG-3 0 ). The fragment was cloned and sequenced to verify its authenticity. The rat blot was similarly probed, with a 400 bp cDNA containing the 5 0 UTR of rat NRAGE. Probes were radiolabeled with 32 P-dCTP (Amersham) by random priming, and hybridizations were performed using the ExpressHyb system (Clontech) according to manufacturers recommended protocol.
In situ hybridization
In situ hybridization of murine sections were performed according to the method of Groves et al. (1995) NTR sequence were also generated.
Briefly, slides were dewaxed in a series of three xylene washes, then hydrated in a graded ethanol series (100, 90, 70, 50%), washed twice in RNAse-free PBS and incubated for 20 min in 0.2 N HCl-DEPC H 2 O. Subsequently, slides were washed twice in 2 £ SSC for 5 min and then incubated at 558C in prehybridization buffer (Groves et al., 1995) for 120 min. At this point, the prehybridization was replaced with fresh prehybridization buffer containing 1 mg/ml riboprobe and hybridization allowed to occur overnight at 558C.
Following hybridization, slides were treated with 20 mg/ ml RNAse A and washed in a series increasing stringency for 10 min at 458C as described elsewhere (Groves et al., 1995) . After washing, sections were incubated at room temperature (RT) in TBST and 10% goat serum (blocking buffer) for 1 h at which point the blocking solution was removed and fresh blocking buffer containing a 1/200 dilution of anti-digoxigenin-alkaline phosphatase fab fragments (Roche) applied overnight at 48C. Following the incubation, slides were washed in a solution containing 100 mM Tris pH 9.5, 50 mM MgCl 2 , 100 mM NaCl, 0.1% Tween-20 (AP buffer). Visualization of bound probe was performed by incubating slides in AP buffer containing 75 mg/ml Nitro blue tetrazolium, 50 mg/ml 5-bromo-4-chloro-3-indoylphosphate (Roche) and 5 mM levamisole (Sigma) for up to 4 h. Sections were washed extensively in PBS. NRAGE mRNA expression was visualized on an Olympus 1 £ 70 microscope using bright field illumination (Olympus).
Immunohistochemistry
In this study, two affinity purified NRAGE specific polyclonal antibodies were employed. Both a-NRAGE antibodies were generated from GST fusion constructs encoding --- either the N-terminal 31-396 amino acids or amino acids 53-295 of rat NRAGE (Salehi et al., 2000) . These antibodies were designed to avoid cross-reactivity with the necdin and MAGE homology domains of NRAGE. Unless stated, all immunohistochemical procedures occurred at RT for 1 h. Slides were dewaxed in a series of three xylene washes for 5 min each. Then hydrated in a graded ethanol series [100, 90, 70% including 1% Sudan black B to prevent tissue autofluorescence (Sigma), 50%] and washed in PBS. Sections were incubated for 1 h at RT in blocking buffer (10% goat serum in PBS) prior to the addition of NRAGE specific antibodies (1/100 dilution in fresh blocking buffer). Sections were then thoroughly washed in PBS before the appropriate secondary antibodies (1/200 dilution, Chemicon) were applied. Sections were then washed in PBS for 10 min and incubated for an additional 10 min in PBS containing 1 mg/ml Hoechst 33258 (Sigma). Sections were again thoroughly washed in PBS and staining visualized on an Olympus 1 £ 70 fluorescent microscope.
For the cellular determination of NRAGE expression, adherent cortical cultures were fixed in 4% PFA in PBS (10 min), rinsed in PBS and co-labeled with the a-NRAGE polyclonal antibodies and monoclonal antibodies against either the neuronal markers, neurofilament-68 (NF-68), neurofilament-200 (NF-200) and MAP2a/b or the glial specific marker, glial fibrillary acidic protein (GFAP) (Sigma). Appropriate species and isotype specific secondary antibodies conjugated to FITC or Rhodamine were used as secondary detection reagents together with Hoechst 33258 (1 mg/ml).
Semi-quantitative RT-PCR
Total RNA was isolated with Trizol (Invitrogen) as per manufacturer's specifications. Total RNA was treated with DNAse I (78 U/ml) (Invitrogen) to eliminate any potential genomic contamination and reprecipitated. cDNA was synthesized from 5 mg total RNA with Superscript II (Invitrogen) using an Oligo (dT) 12-18 primer according to previously published procedures .
All PCR reactions were performed in the linear range of amplification as determined empirically for each cDNA sample generated. An 800 bp cDNA fragment was amplified using specific primers for NRAGE that lie outside the MAGE domain. A 300 bp b-actin fragment was also amplified as a positive control and used for semi-quantitative purposes. For NRAGE the forward primer sequence was 568C, 30 s; extension 728C, 40 s] using 1/20th of the generated cDNA. PCR products were separated on a 1% agarose gel and visualized with ethidium bromide. Resulting amplification products were analyzed using a Kodak Electrophoresis Documentation and Analysis System 120 unit. The ratio of the net intensity of actin amplification to the net intensity of the NRAGE amplification product resulted in the relative NRAGE mRNA expression level.
Western blotting
Western blots were prepared using adult and fetal CD1 mouse tissues collected from E10 to E21 solublized in Trizol (Invitrogen) and protein was obtained by exhaustive dialysis of the phenol-ethanol supernatant against 0.1% SDS, quantitated using the BCA assay (Smith et al., 1985) , and fractionated by 8% sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions. After semi-dry transfer onto Immobilon-P (Millipore), membranes were probed with either polyclonal rabbit a-NRAGE antibodies. Blots were developed using horseradish peroxidase conjugated-goat anti-rabbit IgG (Jackson Immuno Research Laboratories Inc.) and a chemiluminescent reagent (New England Nuclear), and exposed to Fujifilm.
Mouse brain cortical cultures
Timed pregnant mice were sacrificed at E13 and the embryos were aseptically removed and placed in Hank's balanced salt solution (HBSS) (Invitrogen) supplemented with 10% fetal bovine serum (FBS). Cerebral cortex was removed, freed of meninges, dispersed with 0.05% trypsin-EDTA and filtered with 70 mm nylon cell strainers (VWR). Cells were seeded (2 £ 10 5 cells/ml) on poly-d-lysine coated 60 mm dishes in a medium containing 38% neurobasal medium, 60% DMEM/F12, 2% FBS, and 0.4 ml/ml penicillin/streptomycin (Invitrogen). Once adherent (within a few hours), the cells were allowed to differentiate for 5 days in serum-ree media comprising 40% Neurobasal medium, 60% DMEM/F12, and N2 supplements (0.6% dglucose, 10 mg/l insulin, 20 mg/l transferring, 61 mM putrescine-HCl, 20 nM progesterone and 30 nM sodium selenite) (Mazzoni and Kenigsberg, 1991) . Cortical astrocyte cultures were generated from E13 mouse brain by seeding cortical progenitors as above and differentiating the adherent cells in DMEM, high glucose, l-glutamine, 10% FBS and 0.4 ml/ml PS for 2 weeks.
Results
NRAGE mRNA is ubiquitous throughout development
The p75 NTR has been implicated in mediating apoptosis both in vitro and in vivo. The demonstration that three p75 NTR interacting proteins facilitate neurotrophin-induced apoptosis in a p75 NTR -dependent manner in vitro further lends credence to the hypothesis that p75
NTR is a pro-apoptotic receptor. We wished to determine whether one such mediator of p75 NTR signaling, NRAGE, was expressed in temporal and spatial accordance to mediate such a function. To determine NRAGE gene expression across development, a mouse developmental Northern blot was probed for NRAGE using a 300 bp segment of the 5 0 UTR of NRAGE to avoid the MAGE homology domain, thus insuring our results would not be confounded with other MAGE family members. A single 2.9 kb band, representing the full length mRNA was detected at the earliest time point represented (E7) and at all subsequent ages examined (Fig. 1A) . Examination of NRAGE mRNA expression at earlier embryonic ages by reverse transcription-polymerase chain reaction (RT-PCR) revealed expression at all ages tested (E3-E6) and in murine embryonic stem cells (data not shown). The presence of NRAGE gene expression at stages of development prior to the onset of neurogenesis or germ layer specification indicates a possible role for NRAGE other than mediating p75 NTR /neurotrophin-induced apoptosis. In general, MAGE family members are expressed only in tumour cells with the one major exception being the neuron specific MAGE member necdin and the recently described MAGED1 (Lucas et al., 1999; Pold et al., 1999; Kubu et al., 2000; Niinobe et al., 2000) . We then addressed whether NRAGE, like necdin, was predominately expressed in the nervous system or was more similar to the ubiquitous expression of MAGED1 (Lucas et al., 1999) . Probing of an adult rat tissue and human tissue Northern blot using the NRAGE specific probe, revealed that unlike necdin and most other MAGE genes, NRAGE mRNA expression was detected in most tissues. An expression profile that was more similar to MAGED1 (Lucas et al., 1999) (Fig. 1B, C) . In the rat, the highest levels of expression were detected in the brain and liver with lower levels found in the remaining tissues examined. NRAGE expression pattern in human tissues was also wide spread. NRAGE mRNA was once again most prevalent in the brain, but in contrast to the tissue distribution of NRAGE mRNA in the adult rat, high levels of transcripts were also expressed in the lung and kidney with little expression in the liver. Moreover, NRAGE was detected in both skeletal muscle and spleen in adult human tissues, two tissues in rat where the levels of NRAGE mRNA were just above the threshold of detection. These differences in expression patterns and levels may reflect either differing physiological functions or tissue regulation of NRAGE between species. The significance of the expansive tissue distribution demonstrates the unique and atypical expression pattern of MAGED1 subfamily members. The diverse nature of NRAGE's tissues distribution indicates potential physiological relevance throughout development and into adulthood and may not be limited to signaling events transduced through the p75 NTR . The pleiotropic nature of NRAGE's physiological functions was hypothesized to be demonstrated through its gene expression distribution. Since, the highest levels of NRAGE expression were detected in rat and human brain, we asked whether this reflected a generally higher expression level of NRAGE mRNA throughout the entire brain or whether a subset of specific brain regions express varying amounts of transcripts. In addition, because each specific brain region develops at different time points during gestation, we were interested whether individual structures express NRAGE mRNA at varying levels based on their respective stages of development. To this end, we sectioned mouse embryos from E7 through adulthood and performed in situ hybridization using an NRAGE and p75 NTR specific riboprobe. We employed riboprobes to increase our sensitivity and NRAGE specificity. Negative control (sense) riboprobes revealed no staining (Fig. 2F, L, P) . Moreover, no background or signal was detected when slides were pre-treated with RNAse A and antisense probes utilized (data not shown). Consistent with our Northern analysis, the E7 egg cylinder was found to express NRAGE (data not shown). However, the invading syncytiotrophoblast, the outer syncytial layer of the trophoblast that covers each chorionic villus of the placenta, and surrounding uterine tissue also expressed NRAGE. The presence of NRAGE in the syncytiotrophoblast is consistent with previous studies having identified MAGE gene expression in placental tissue (Hara et al., 1999) . From E8 to E11 NRAGE mRNA was identified in all regions of the developing neural tube (Fig.  2A) . There was no apparent restriction of NRAGE expression to any particular brain segment and within each region, high levels of expression were observed throughout the neuroepithelium. Within the spinal cord, NRAGE was observed within the mantle zone (Fig. 2G) . Similarly, p75 NTR gene expression during early neural development paralleled that of NRAGE. p75
NTR message was detected in the subventricular zone (Fig. 2M ) and within the mantle zone of the spinal cord (data not shown).
This pattern of NRAGE tissue expression was observed until approximately E14 at which point a change in spatial distribution of message was observed. By E15, a prominent band of NRAGE gene expression was detected within the subplate and ventricular zone (Fig. 2B) . The mantle zone of the spinal cord continued to express NRAGE (Fig. 2H) as well as p75 NTR (Fig. 2N ). This segregation was complete by E16 where distinct bands of NRAGE mRNA expression are well defined within the ventricular, subplate and cortical plate zones (Fig. 2C, I ). These distinct cortical regions, cortical plate, subplate and ventricular zone continued to express NRAGE mRNA into postnatal life (Fig. 2D, J) , whereas p75 NTR was predominantly restricted to the subplate zone (Fig. 2O ) at this and subsequent ages.
The adult brain was also found to express NRAGE. Within the cortex, NRAGE positive cells can be identified throughout layers I-VI (Fig. 2K) . The dentate gyrus, CA1 and CA3 regions of the hippocampus are also major sources of NRAGE mRNA in the adult brain (Fig. 2E) . NRAGE mRNA was detected in numerous brain structures including, but not limited to: the neocortex, striatum, pallidum, hippocampus, thalamus, hypothalamus, tegmentum, tectum, cerebellum, pons, medulla and the spinal cord. NRAGE was also present in neural structures such as the developing pituitary or Rathke's pouch, the optic and olfactory neuroepithelium, dorsal root ganglia (DRG), superior cervical ganglia and the sympathetic chain.
NRAGE protein undergoes spatial regulation
NRAGE mRNA undergoes a gradual spatial restriction as development progresses. We asked whether the protein follows the unique characteristics of the mRNA. To this end, we performed immunohistochemistry on serial mouse embryonic sections from E7 through adulthood. We utilized two distinct affinity purified NRAGE polyclonal antibodies: one generated to the peptide residues (53-295) of rat NRAGE and a second generated against peptides (31-396). The antibodies cross-react with rat, mouse and human protein isoforms (data not shown). There was no difference in the overall staining pattern using the two distinct antibody species. The protein expression of NRAGE revealed a similar distribution pattern to the mRNA. NRAGE protein was observable within the E7 egg cylinder and in the uterine tissue (data not shown). At E10-E13 NRAGE, immunoreactive cells can be observed in the proliferative neural tube (Fig. 3A, B) . Like the mRNA, the mantle zone of the spinal cord also expressed NRAGE protein (Fig. 3D) . In addition to the CNS, neurotrophin sensitive populations in peripheral nervous namely the DRG and sympathetic ganglia also express NRAGE (Fig.  3D, F) .
Complementary to the compartmentalization of NRAGE mRNA in the neural tube, the protein also became restricted within distinct bands in the cortical, subplate and ventricular zones at E15 (Fig. 3E) . Furthermore, NRAGE continued to be expressed within the mantle zone of the spinal cord (data not shown). Like the mRNA, NRAGE protein was observed in various subpopulations of cells including the neocortex, striatum, pallidum, hippocampus, thalamus, hypothalamus, tegmentum, tectum, cerebellum, pons, medulla and the spinal cord. NRAGE positive cells within the cortical and subplate zones may represent migratory neuroblasts that have recently moved from the ventricular zone. Therefore, NRAGE protein is present through the entire neuroepithelial wall within each brain region during early neural development. However, by late development cells within the proliferative ventricular zone and the transient cortical and subplate zones express NRAGE protein.
In general, cells within the ventricular zone during early neurogenesis are neural precursor cells. These cells migrate out as development progresses to form the transient subplate and cortical plate zones. These rudimentary structures act as building blocks to form the cortical laminae in the adult. The localization of NRAGE to these layers prompted an investigation as to the cellular specificity of NRAGE expression. Immunohistochemistry was performed on developing cortical neuronal and glial cultures generated from E13 embryos to co-localize NRAGE protein expression with either the expression of the early neural specific marker neurofilament-68 (NF-68) (Paterno et al., 1997; Pyle et al., 2001) , or the glial specific marker GFAP. NRAGE expression was found in both the neural and glial subpopulations. (Fig. 4A, B, D, E) . However, NRAGE protein did not co-localize with later, more mature neuronal markers such as MAP2a/b (Tanaka et al., 1992) (Fig. 4C, F, G) suggesting that postmitotic or maturing neurons attenuate or turn off the expression of NRAGE protein. Therefore, this result also suggests that NRAGE protein is not expressed within neuronal populations undergoing active neurotrophin competitive programmed cell death. Further research is required to assess NRAGE protein in more mature astrocytic or oligodendrocytes cultures.
Collectively, these data demonstrate that during embryonic neurogenesis in the CNS NRAGE spatial distribution is regulated at both the mRNA and consequently at the protein level. NRAGE protein is expressed in all brain regions. Within the cortex, NRAGE is specifically localized to the cortical, subplate and ventricular zones. In the remainder of the brain, NRAGE is expressed within both the ventricular and subventricular zones and is restricted to neural precursors and immature neuronal populations.
NRAGE protein is temporally regulated throughout development
NRAGE potentially has multifaceted functions and thus a description of expression across development is expected to reflect endogenous physiological activities. The spatial distribution data supports the bipotential role of NRAGE during development. Therefore, a similar mechanism regulating the temporal distribution of NRAGE is expected to reflect its diverse developmental regulation. We, therefore, sought to characterize NRAGE mRNA and protein expression patterns across development. Utilizing semi-quantitative RT-PCR in conjunction with Western blotting we analyzed the temporal expression of NRAGE message and protein in most major embryonic and adult mouse tissues (for a complete list of tissues assayed see Table 1 ).
NRAGE mRNA was identified at all developmental ages for each tissue assessed with the exception of fetal and adult blood (Table 1) . A common pattern of mRNA expression was observed regardless of the tissue assessed. This is demonstrated by the ratio of NRAGE message to actin message within the nervous system. The relative level of NRAGE mRNA was constitutively expressed throughout development (Fig. 5A, B) . For every tissue examined, only minimal modulation in mRNA message was observed during embryogenesis through adulthood. Intriguingly, a major exception to this typical NRAGE mRNA profile occurred within the developing thoracic neural tube. In the First strand cDNA amplification of NRAGE resulting in a ,800 bp fragment or ,300 bp b-actin fragment and Western blots of NRAGE with an approximate molecular weight of 97 kDa. Note NRAGE mRNA was identified at all ages, whereas the protein is regulated in a tissue specific manner. (B) The graph outlines the relative quantitation of NRAGE mRNA across development as depicted from A. NRAGE levels are equilibrated to actin levels for each age and expressed as a ratio to the E10 NRAGE/actin levels, or E12 for the sacral neural tube. An n ¼ 4 for is represented in the graph. (C) Semi-quantitative RT-PCR analysis of B2region that both the NGF-dependent DRG and sympathetic ganglia reside, there was an elevation in both protein and mRNA message levels commencing at day E14 and again at E18 for the mRNA (Fig. 5B ). Since our segments included several cell populations, we focused specifically on the expression within the developing DRG and thoracolumbar sympathetic chain over gestation (E14-E18). To this end, DRGs and B2 1 sympathetic neuroblasts were isolated and RNA and protein extracted. The level of NRAGE message during gestation mimicked what was observed in our thoracic neural tube segments except the elevation of NRAGE mRNA was significantly enhanced (,3-fold) (Fig. 5C) . Due to the limitation in cell number, we were not able to quantify whether the raise in protein matched the rise in massage, but since a rise in protein was also detected in the thoracic section studies we assume a significant rise in protein would follow.
Characterization of NRAGE protein expression demonstrates a distinct pattern of tissue expression regulation compared to the mRNA. Unlike the constitutive mRNA expression, the expression of NRAGE protein is under stringent temporal regulation (Fig. 5A) . Within the developing mouse nervous system, NRAGE protein appears as early as E7 (first day examined) but by P1 unlike the mRNA, protein levels were under the limits of detection, even after prolonged exposure times and increasing the concentrations of the two NRAGE specific antibodies used.
Specifically, NRAGE protein levels were identified during brain development maximally at E9-E10 and then decreasing at E12, remaining low until birth when the protein is virtually undetectable. The heaviest staining of NRAGE protein was observed between E12 andE14 in the thoracic region, including dorsal root and sympathetic ganglia. Expression was detected until E20, a key chronological landmark since trophic mediated survival begins as early as E16 and continues into postnatal life (Farinas, 1999) . The presence of NRAGE protein in this segment and within these neurotrophin sensitive populations supports a role for NRAGE in this process, consistent to the observations of Salehi et al. (2000) . In the latter tissues, NRAGE appears to migrate as a doublet, possibly reflecting post-translational protein modification. In the thoracic neural tube, the upper band of this 97K doublet is particularly prominent at E16. Possible phosphorylation and/or ubiquitination are currently being assessed as an explanation for this shift in NRAGE expression. These data indicate that despite constitutive levels of NRAGE message, the temporal expression of the NRAGE protein constitutes the greatest level of regulation.
Discussion
We have analyzed the expression of NRAGE, a member of the ever-growing MAGE gene family, during murine embryogenesis in order to attempt to correlate the gene expression with potential functions during development.
Both the mRNA and protein are widely expressed. NRAGE mRNA was identified at the earliest embryonic day tested (E3) and the protein was found from E7 through adulthood, depending on the tissue assessed. The mRNA is constitutively expressed from embryogenesis to adulthood. However, the protein undergoes tissue specific structural and temporal regulation across development suggesting that the strongest regulation of NRAGE expression is post-transcriptional. In the developing nervous system, peak levels (E12) occur during early development when the brain and spinal cord are undergoing rapid proliferation and expansion. NRAGE mRNA and protein were apparent in all brain regions with expression detected throughout the entire neuroepithelial wall during early stages of neurogenesis. During later stages of neurogenesis, NRAGE was specifically localized to the cortical plate, subplate plate and ventricular zone of the cortex. Both the ventricular and subventricular zone of the midbrain and hindbrain express NRAGE and this expression is probably restricted to neural precursors or immature neurons since NRAGE colocalizes exclusively in within NF-68 positive cells. Localization of NRAGE to the proliferative ventricular zone is suggestive of a role in cell cycle regulation or early neural progenitors, whereas expression within the subplate and cortical plate correlates with areas where postmitotic neurons undergo cell death mediated by the traditional neurotrophic hypothesis.
NRAGE, like its closest family members MAGED1 is expressed in most tissues examined, supportive of a potential essential role for the cellular function of NRAGE. However, elucidation that cellular function has proven difficult to assess due to the very low levels of detectable of endogenous and transfected protein expression in a variety of primary and cell lines, e.g. COS7, PC12, P19, U87, C6, MAH and 293 cells (S.K., D.G., and J.M.V., unpublished results). This narrow range of accumulation of NRAGE protein in these cell lines indicates stringent regulation for cell viability and/or normal cellular proliferation. Overexpression of NRAGE protein appears to be toxic to recipient cells, and the proportion of successfully transfected cells that express tagged NRAGE cDNAs is extremely low. Taken together that transfected cells also reduces proliferative levels (Salehi et al., 2000) it is possible that only cells in a particular stage of their cell cycle allow for the over-expression of NRAGE. These results are in agreement with previous findings from Casademunt et al. (1999) indicating poor cellular expression of transfected NRIF, possibly via a cell cycle-dependent mechanism.
4.1. In the PNS NRAGE correlates with sensory and sympathetic neuron p75 NTR mediated apoptosis
For neural tube development, NRAGE is present when motoneurons of the floor plate are beginning to undergo trophic-dependent programmed cell death (Yamamoto and Henderson, 1999) and the lateral motor column shows high levels of p75 NTR expression at this time (Ernfors et al., 1988) . NRAGE has previously been detected in motoneurons (Salehi et al., 2000) . However, the importance of p75 NTR mediating apoptosis within motoneuron pools in vivo has been questioned since p75 NTR deficient mice fail to display any significant loss in motoneuron populations (Wiese et al., 1999; Murray et al., 1999) .
The neural tube dissections allowed for the collection of both the sympathetic and dorsal root ganglia. The presence and timing of expression of Trk and p75 NTR in both these structures has been well documented (Ernfors et al., 1988; Lee et al., 1994a; Bamji et al., 1998) Moreover, p75 NTR has been shown to be required for promoting apoptosis in these neuronal populations (Lee et al., 1994a; Lee et al., 1994b; Bamji et al., 1998; Murray et al., 1999) . The timing of sensory and sympathetic neurotrophic-dependent cell death commences at approximately E14 and E17, respectively (Barrett and Bartlett, 1994; Farinas, 1999) . Unlike the CNS where NRAGE protein is diminished prior to the onset of neurotrophin mediated cell death, NRAGE is expressed in the DRGs and sympathetic ganglia prior and during the period of programmed cell death.
The expression of NRAGE within the purified B2 1 population of sympathetic neuroblasts reveals an interesting insight into the potential function of NRAGE in the PNS. Both NRAGE protein and message are expressed in sympathetic neuroblasts, yet p75 NTR is only expressed after the onset of mitotic arrest (Ernfors et al., 1988; . This means that if NRAGE mediates the cell cycle withdrawal of committed neuroblasts it is through a p75 independent mechanism.
So what if any function does NRAGE and p75 NTR interactions have in the formation of the PNS? It is possible that NRAGE-p75 NTR work to cull neurons that reach their targets but have failed to reach sufficient levels of Trk on their cell surface making apoptosis an instructed extrinsic event (p75 NTR -NRAGE) as apposed to a default intrinsic pathway lacking NGF stimulation. This would be a twist on the classical neurotrophic theory in that neurons which do not receive sufficient neurotrophic support from lack of Trk-NGF die as a consequence, but also may be instructed to undergo apoptosis as a result of NGF-p75 NTR -NRAGE activation.
In the CNS NRAGE protein expression correlates with timing of a p75
NTR -independent neural precursor apoptosis During brain development NRAGE is present predominantly during the stages when the ventricular and subventricular regions are undergoing rapid proliferation of neural precursor cells. Concomitant with differentiation and migration of neuroblasts from the ventricular region, NRAGE localizes to this proliferative layer. Although, the spatial distribution of NRAGE protein is largely independent of p75 NTR receptor expression within the brain NRAGE does co-localize with p75 NTR in the subplate region. p75 NTR has been detected within the subplate in rat, primate and human species cerebral cortex (Yan and Johnson, 1988; Schatteman et al., 1988; Kordower and Mufson, 1992; Mackarehtschian et al., 1999) . Furthermore, p75 NTR has recently been shown to promote survival of subplate neurons in vitro in a Trk independent fashion (DeFreitas et al., 2001) . In addition to the subplate, NRAGE co-localizes with p75 NTR in basal forebrain cholinergic neurons located in the medial septum, diagonal band of Broca, nucleus basalis and striatum (Hartikka and Hefti, 1988 , Schatteman et al., 1988 , Koh et al., 1989 , Koh and Higgins, 1991 . The basal forebrain has been shown to be sensitive to NGF-induced apoptosis . However, an involvement of NRAGE in mediating apoptosis in the striatum has yet to be determined.
Taken together these results do not preclude the possibility that NRAGE is involved in a p75 NTR -mediated neural apoptosis. However, this does not seem likely since NRAGE levels are significantly reduced during the timing of trophic-dependent apoptosis. However, the significant level of NRAGE in the ventricular zone certainly indicates an ancillary function to that of p75 NTR . Like necdin, NRAGE functions as a growth arrest protein and may function in mediating mitotic arrest when neuroblasts are beginning to differentiate and migrate from the ventricular zone.
The fact that NRAGE may possess roles apart from p75 NTR during development does not exclude a pro-apoptotic function in a cell cycle-dependent manner within the brain. Previous studies have shown that molecules acting during cell cycles progression are required for apoptosis. These include mitotic kinases (Meikrantz et al., 1994) , the tumour suppressor gene p53 which is required for neural precursor cell apoptosis (D'Sa-Eipper et al., 2001 ) and cyclin D 1 (Freeman et al., 1994) . There is growing support indicating the existence of two functionally distinct types of programmed cell death in the nervous system of developing mammals. This early neural cell death affects neural precursor cells and young neuroblasts involved in an active mitotic cycle, whereas trophic-dependent cell death involves postmitotic neurons (de la Rosa and de Pablo, 2000) . Recent estimates indicate that between 50 and70% of cortical neuroblasts in the proliferative ventricular zone undergo apoptosis in murine and primate species (Blaschke et al., 1996; Blaschke et al., 1998) . While the precise number of neural precursor cells undergoing apoptosis is under debate (Simonati et al., 1997; Thomaidou et al., 1997; Strom and Williams, 1998; Haydar et al., 1999 ) the importance of this developmental event has been inferred from the studies of caspase-3, -9 and APAF-1 deficient mice. These knockout mice all exhibit marked ventricular zone expansion (Kuida et al., 1996; Cecconi et al., 1998; Kuida et al., 1998; Pompeiano et al., 2000) . The selective enlargement of the ventricular zone during early neurogenesis suggests that caspase-3, -9 and APAF-1 functions are essential for apoptosis during early development of the CNS and that in the absence of normal neural precursor apoptosis cell develop-ment is abnormal (Sommer and Rao, 2002) . Timing of neural precursor apoptosis within the CNS is region specific, generally cell death commences at around E10, reaching a peak around E14, and then decreasing postnatally to low levels seen in the adult. This early-programmed cell death coincides very well with both the spatial and temporal distribution of NRAGE. Taken together with the fact that NRAGE levels peak just prior to the onset of the neural precursor apoptosis and that concurrently the first cortical neurons are exiting the cell cycle at E15 (Caviness, 1982) it becomes important to determine whether NRAGE may function as a molecular switch between cell proliferation and apoptosis for neural precursor cells in the developing mouse cerebral cortex.
Other studies are also consistent with the operation of extensive neuroproliferative apoptosis related to the progression of the cell cycle. Thomaidou et al. (1997) have demonstrated that the commitment to die in the developing ventricular zone of the cerebral cortex is integrally related to the G1 to S transition. A primary function in linking cell cycle and cell death is exerted by proteins acting as cell cycle checkpoints. A key regulator of the G1 to S transition is E2F-1 (Weinberg, 1992) and mice lacking E2F-1 have a suppressed level of apoptosis (Field et al., 1996) . The p53 protein is another transcriptional regulator of the G1 to S transition and is also involved in promoting apoptosis of neural precursor cells in a caspase-dependent manner (D'Sa-Eipper et al., 2001 ). Thus, it appears that cell cycle proteins are important, for at least some apoptotic mechanisms that result in the activation of caspases during early neural cell death. However, further research is required to draw definitive concludes pertaining to NRAGE activity during neural precursor apoptosis.
NRAGE was also identified in many other non-neural tissues throughout development. Similarly the p75 NTR receptor is expressed in a variety of other non-neural tissues, both in the embryo and the adult. The gross tissue distribution of NRAGE is in agreement with the distribution of p75 NTR previously characterized in rats (MacGrogan et al., 1992, Lomen-Hoerth and Shooter, 1995) . However, our result also identified non-neural regions that are not known to express p75 NTR . Therefore, these results can be attributed to the proposed diverse nature of NRAGE's endogenous function as a growth arrest protein and as a mediator of a p75 NTR -independent pro-apoptotic signaling factor. Within the majority of tissues NRAGE expression is correlated within populations of renewable cells and immature differentiated phenotypes, for example the testis (spermatozoa production), intestine (epithelial turnover), skin (dermis), spleen (lymphocyte production), liver (hepatocyte turnover), pregnant uterus, and olfactory bulb and neural precursor cells of the adult brain.
The expression of NRAGE throughout early stages of embryogenesis suggests that this protein plays an important signaling role(s) in the development of the neural tube, brain and many non-neural tissues as well. The function of NRAGE at these early times may not be mediated through neurotrophin p75
NTR interactions, as we observed in the thoracolumbar B2 1 population. In this population of purified sympathetic neuroblasts, NRAGE expression correlates with excite from the cell cycle prior to expression of Trk or p75 NTR . However, under strict spatial and temporal regulation when expressed in the presence of p75 NTR , NRAGE may mediate an NGF cell death-signaling cascade. This may be a novel mechanism by, which sympathetic and presumable sensory neuroblasts that do not express TrkA or insufficient levels of TrkA may be culled from the population of innervating neuroblasts. When expressed in the absence of p75 NTR under a different set of spatial, temporal and possibly structural regulations, NRAGE may induce cell cycle arrest potentially leading to apoptosis through a novel mechanism.
